Mosedipimod is is a synthetic version of a monoacetyldiacylglyceride which is a naturally occurring compound found in various seed oils, bovine udder and milk fat, antlers of sika deer, with potential antineoplastic activity. It acts as an immunomodulator with anti-inflammatory and anticancer activity, being developed by Enzychem Lifesciences, for the treatment of cancer.